Sort
172,184 grants matching “inflammation”
UAB Multidisciplinary Clinical Research Center
$839,151S Louis Bridges · University Of Alabama At Birmingham · P60 · FY2016 · AR
Sustained Release Inner Ear Delivery of Corticosteroid
$839,147William H Slattery · O-Ray Pharma, Inc. · R44 · FY2014 · DC
Effects of a major natural disaster on the pace of aging in a nonhuman primate model
$839,120James P Higham · New York University · R56 · FY2021 · AG
The Female Reproductive Tract as a Portal of HIV Infection
$839,093Linda C Giudice · J. David Gladstone Institutes · P01 · FY2012 · AI
Quantifying cardiac structure and function to define the progression to hear failure in African Americans
$839,070Amil M Shah · Brigham And Women'S Hospital · R01 · FY2020 · HL
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women
$838,967Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2009 · HL
Effect of lipid modification on peripheral arterial disease (PAD)
$838,966Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2007 · HL
Multidimensional phenotype classification in grade 3 BPD
$838,922Krithika Lingappan · Children'S Hosp Of Philadelphia · R01 · FY2025 · HL
Evaluation of small-fiber polyneuropathy as a cause of chronic widespread pain in youth
$838,805Anne Louise Oaklander · Massachusetts General Hospital · R01 · FY2017 · NS
Pneumonia Biology
$838,786Joseph P Mizgerd · Boston University Medical Campus · R35 · FY2021 · HL
Pneumonia Biology
$838,786Joseph P Mizgerd · Boston University Medical Campus · R35 · FY2022 · HL
Pneumonia Biology
$838,786Joseph P Mizgerd · Boston University Medical Campus · R35 · FY2019 · HL
Pneumonia Biology
$838,786Joseph P Mizgerd · Boston University Medical Campus · R35 · FY2020 · HL
Pneumonia Biology
$838,786Joseph P Mizgerd · Boston University Medical Campus · R35 · FY2023 · HL
Pharmacogenomics of HIV Therapy
$838,752David W Haas · Vanderbilt University Medical Center · R01 · FY2021 · AI
Preclinical modeling to study Tuberculous Meningitis
$838,739Sanjay Jain · Johns Hopkins University · R56 · FY2019 · AI
A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy
$838,708Cohava Gelber · Serpin Pharma, Llc · R44 · FY2024 · CA
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
$838,670Jason S Debley · Seattle Children'S Hospital · R01 · FY2025 · AI
Role of ZBP1 in pathogenesis of Salmonella biofilms
$838,667Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · AI
Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans
$838,599Gene H Brody · University Of Georgia · P30 · FY2016 · DA
Systems Approach to Immunity and Inflammation
$838,582Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2020 · AI
Evaluating the role of opioid medication assisted therapies in HIV-1 Persistence for persons living with HIV and opioid use disorders
$838,513Sandra Ann Springer · Yale University · R33 · FY2021 · DA
HIV Nef Function and Early Events in Macrophage and Microglia Infection
$838,513Jon W Marsh · National Institute Of Mental Health · Z01 · FY2008 · MH
Tumor microenvironments determing migration, dissemination and dormancy
$838,472John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2011 · CA
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
$838,469Allan Doctor · Washington University · R01 · FY2015 · GM